secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001171843-26-002061
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solésence FY2025 rev $62.1M (+19%), net income drops to $1.8M from $4.2M
------------------------------------------------------------------------

- Full-year revenue $62.1M, up 19% YoY; net income $1.8M vs $4.2M in 2024.
- Q4 revenue $12.5M (flat); gross margin improved to 27% from 22%; net income $0.2M vs loss $0.6M.
- Launched Transform & Transcend initiative focusing on operational excellence and globalization.
- Appointed Yoolie Park as VP Brand Partnerships; added 20 new beauty brand partners.
- Expanded patent portfolio to 16 patents including Kleair™ skin health technology.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184326002061/0001171843-26-002061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184326002061/f8k_033126.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-002061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer